Clinical Trial Update: SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

View source ↗

Summary

Completed clinical trial comparing immune checkpoint inhibitors versus non-ICI therapies for cutaneous adverse events, including Stevens-Johnson syndrome and to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatitis
• Stevens-johnson Syndrome
• Toxic Epidermal Necrolysis

Drugs mentioned

• Immune checkpoint inhibitors (various)

Snippet

Sponsor: Chao Ji | Conditions: Immune Checkpoint Inhibitor-Induced Dermatitis, Stevens-Johnson Syndrome, Drug-Induced | Status: COMPLETED